Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3948 Target Snapshot

Type-1 angiotensin II receptor · SINGLE PROTEIN · Oryctolagus cuniculus

1,217Compounds
116Assays
3Approved Drugs
1,465.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P34976. Use UniProt P34976 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P34976 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Type-1 angiotensin II receptor as ChEMBL target CHEMBL3948, mapped to UniProt P34976. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Type-1 angiotensin II receptor
SINGLE PROTEIN · Oryctolagus cuniculus
As of 2026-09-13
ChEMBL target ID
CHEMBL3948
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P34976
Type-1 angiotensin II receptor
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Type-1 angiotensin II receptor is the right protein anchor across sources, using UniProt P34976 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelType-1 angiotensin II receptor
UniProt AccessionP34976
Component TypeProtein
Sequence Length359 aa

Type-1 angiotensin II receptor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Type-1 angiotensin II receptor, mapped to UniProt P34976. Sequence length is 359 aa.

Mapped IDP34976
Review nameType-1 angiotensin II receptor
OrganismOryctolagus cuniculus
Clinical Profile

Clinical Phase Distribution

3
Approved
3
Phase III
2
Phase II
Assay Mix

Activity Type Distribution

IC501,318.0
KI6.0
EC502.0
KD139.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL138690 10.37 IC50 0.043 Preclinical
CHEMBL293511 10.3 Kd 0.05012 Preclinical
CHEMBL416477 10.3 Kd 0.05012 Preclinical
CHEMBL418226 10.3 Kd 0.05012 Preclinical
CHEMBL265797 10.28 IC50 0.052 Preclinical
CHEMBL48242 10.26 IC50 0.055 Preclinical
CHEMBL152106 10.2 Kd 0.0631 Preclinical
CHEMBL339672 10.14 IC50 0.072 Preclinical
CHEMBL341828 10.14 IC50 0.072 Preclinical
CHEMBL343309 10.1 IC50 0.08 Preclinical
Distribution

pChEMBL Value Distribution

13
5.0
25
5.5
59
6.0
65
6.5
160
7.0
200
7.5
246
8.0
203
8.5
218
9.0
203
9.5
pChEMBL
Approved Drugs

Approved Drugs

CANDESARTAN CILEXETIL
CHEMBL1014
Approved 1998
LOSARTAN
CHEMBL191
Approved 1995
Assay Landscape

Assay Landscape

116
Total Assays
981
Tested Compounds
2
Assay Types
Binding — 73 assays, 981 compounds
BAO Format Assays Compounds Avg pChEMBL
tissue-based format 30 432 8.1
single protein format 28 303 8.4
cell membrane format 12 195 8.9
assay format 2 28 7.7
organism-based format 1 23 9.1
Functional — 43 assays, 296 compounds
BAO Format Assays Compounds Avg pChEMBL
tissue-based format 29 168 8.1
assay format 11 37 7.7
cell membrane format 3 91 7.8

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine